Christian Hwee Yee Heng

Christian Hwee Yee Heng

Auto-generated profile, based on publicly available information

Christian Hwee Yee Heng

Department of Orthopaedic Surgery, Singapore General Hospital, Singapore

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2021 in Arthroscopy Techniques
Verified
Journal Article
Open access
CHChristian Hwee Yee Heng
Christian Hwee Yee Heng
MSMartyn Snow
Martyn Snow
LDLee Yee Han Dave
Lee Yee Han Dave
Injectable scaffold augmentation is a promising modality for single‐stage cartilage repair. According to published studies, cartilage repair with scaffold augmentation has improved clinical outcomes, radiological fill, and histological repair compared with microfracture alone. Injectable scaffolds have the versatility to be used in large and irregularly shaped lesions. With correct preparation, they can be applied to lesions on the femoral condyle that may be vertical, or even inverted lesions such as those in the patella. They can be combined with bone marrow aspirate concentrate (BMAC) to provide mesenchymal stem cells (MSCs), thereby avoiding the need for microfracture. This protects the subchondral plate, preventing biomechanical alteration and potentially resulting in improved long‐term outcomes. In this article, we demonstrate the utility of injectable scaffolds and their combination with BMAC. Technique Video: video See video under supplementary data.

9 August 2023 in Arthroscopy, Sports Medicine, and Rehabilitation
Verified
Journal Article
Open access
CHChristian Hwee Yee Heng
Christian Hwee Yee Heng
JWJoel Yat Seng Wong
Joel Yat Seng Wong
ATAndrew Hwee Chye Tan
Andrew Hwee Chye Tan
Purpose: This study aims to compare the outcomes of fixed‐loop device (FLD) vs adjustable‐loop device (ALD) graft fixation with up to 2‐year follow‐up in patients undergoing primary anterior cruciate ligament reconstruction (ACLR) in a predominantly Asian setting. Methods: Prospectively collected outcome measures as well as clinical records of patients who underwent primary ACLR using either FLD or ALD fixation of hamstring tendon autograft performed by a single surgeon were reviewed. The surgeon in this study used a fixed‐loop device from 2018 to 2019 and then changed to adjustable loop from 2019 to 2020. Suspensory fixation was performed on the femoral side, and aperture (interference screw) fixation was performed on the tibial side. Outcome measures included knee range of motion, KT‐1000 arthrometer testing, Lysholm knee score, and Tegner activity scale. Patients were assessed preoperatively and postoperatively at regular intervals of 6, 12, and 24 months. Results: A total of 105 patients were identified. Forty‐six were excluded due to incomplete follow‐up data, so 59 patients with full 2‐year follow‐up were included in the final study group. Both groups (FLD vs ALD) were similar in demographics except for age ( P = .042). Out of 105, there were 59 patients remaining in the study group with 2‐year follow‐up data. No significant differences were observed between the 2 groups at all respective testing intervals. Conclusions: FLDs and ALDs for suspensory fixation of hamstring tendon autograft in ACLR had similar clinical outcomes with a minimum of 2‐year follow up. There is no evidence of graft loosening from loop lengthening. Level of Evidence: Level III, retrospective comparative trial.

2 December 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
AMAkiyoshi Miyamoto
Akiyoshi Miyamoto
Masato TanakaMasato Tanaka
Masato Tanaka
AFAngel Oscar Paz Flores
Angel Oscar Paz Flores
DYDongwoo Yu
Dongwoo Yu
MJMukul Jain
Mukul Jain
KUkoji uotani
koji uotani
Objective: Postoperative lymphopenia is reported as an excellent indicator to predict surgical-site infection (SSI) after spine surgery. However, there is still controversy concerning which serological markers can predict spinal SSI. This study aims to evaluate excellent and early indicators for detecting SSI, focusing on spine instrumented surgery. Materials and Methods: This study included 268 patients who underwent spinal instrumented surgery from January 2022 to December 2023 (159 female and 109 male, average 62.9 years). The SSI group included 20 patients, and the non-SSI group comprised 248 patients. Surgical time, intraoperative blood loss, and glycemic levels were measured in both groups. The complete blood cell counts, differential counts, albumin, and C-reactive protein (CRP) levels were measured pre-surgery and postoperative on Days 1, 3, and 7. In comparing the groups, the Mann–Whitney U test analysis was used for continuous variables, while the chi-squared test and Fisher’s exact test were used for dichotomous variables. Results: The incidence of SSI after spinal instrumentation was 7.46% and was relatively higher in scoliosis surgery. The SSI group had significantly longer surgical times (248 min vs. 180 min, p = 0.0004) and a higher intraoperative blood loss (772 mL vs. 372 mL, p < 0.0001) than the non-SSI group. In the SSI group, the Day 3 (10.5 ± 6.2% vs. 13.8 ± 6.0%, p = 0.012) and Day 7 (14.4 ± 4.8% vs. 18.8 ± 7.1%, p = 0.012) lymphocyte ratios were lower than the non-SSI group. Albumin levels on Day 1 in the SSI group were lower than in the non-SSI group (2.94 ± 0.30 mg/dL vs. 3.09 ± 0.38 mg/dL, p = 0.045). There is no difference in CRP and lymphocyte count between the two groups. Conclusions: SSI patients had lower lymphocyte percentages than non-SSI patients, which was a risk factor for SSI, with constant high inflammation. The Day 3 lymphocyte percentage may predict SSI after spinal instrumented surgery.

28 February 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
EAEfe Levent Aras
Efe Levent Aras
Masato TanakaMasato Tanaka
Masato Tanaka
CRChetan Ram
Chetan Ram
CHChristian Heng
Christian Heng
SNSalamalikis Nikolaos
Salamalikis Nikolaos
KUkoji uotani
koji uotani
Meticulous clinical examination is essential for spinal disorders to utilize the diagnostic methods and technologies that strongly support physicians and enhance clinical practice. A significant change in the approach to diagnosing spinal disorders has occurred in the last three decades, which has enhanced a more nuanced understanding of spine pathology. Traditional radiographic methods such as conventional and functional X-rays and CT scans are still the first line in the diagnosis of spinal disorders due to their low cost and accessibility. As more advanced imaging technologies become increasingly available worldwide, there is a constantly increasing trend in MRI scans for detecting spinal pathologies and making treatment decisions. Not only do MRI scans have superior diagnostic capabilities, but they also assist surgeons in performing meticulous preoperative planning, making them currently the most widely used diagnostic tool for spinal disorders. Positron Emission Tomography (PET) can help detect inflammatory lesions, infections, and tumors. Other advanced diagnostic tools such as CT/MRI fusion image, Functional Magnetic Resonance Imaging (fMRI), Upright and Kinetic MRI, magnetic resonance spectroscopy (MRS), diffusion-weighted imaging (DWI), and diffusion tensor imaging (DTI) could play an important role when it comes to detecting more special pathologies. However, some technical difficulties in the daily praxis and their high costs act as obstacles to their further spread. Integrating artificial intelligence and advancements in data analytics and virtual reality promises to enhance spinal procedures’ precision, safety, and efficacy. As these technologies continue to develop, they will play a critical role in transforming spinal surgery. This paradigm shift emphasizes the importance of continuous innovation and adaptability in improving the diagnosis and treatment of spinal disorders.

1 May 2021 in Video Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
CHChristian Hwee Yee Heng
Christian Hwee Yee Heng
YLYee Han Dave Lee
Yee Han Dave Lee
Background: Injectable scaffold augmentation has been gaining traction as a promising modality for single-stage cartilage repair. It involves the use of a biological scaffold that augments microfracture techniques by aiding in clot stabilization and maturation. The scaffold provides a matrix that helps with mesenchymal stem cell (MSC) retention and encourages differentiation along a chondrogenic lineage. Bone marrow aspirate concentrate (BMAC) has also been proposed as an alternative source of MSCs to microfracture, and it can potentially avoid the pitfalls of microfracture techniques. Indications: Injectable scaffold augmentation to microfracture techniques are recommended in lesions >4 cm, as long-term follow-up has shown increasing failure over time with microfracture alone. Technique Description: We describe a technique of autologous matrix-induced chondrogenesis using CartiFill, a porcine-derived type 1 collagen scaffold, combined with BMAC as a source of MSCs (avoiding the use of microfracture). Results: Injectable scaffold augmentation has been shown in recent studies to lead to better radiological fill, higher quality of histological repair, and better clinical outcomes as compared with microfracture alone. These injectable scaffolds have the versatility to be used on lesions which have traditionally been considered difficult to address, such as vertical or inverted lesions. Moreover, the use of scaffolds allows the repair to be further augmented with BMAC which provides a source of MSCs without the need to perform microfracture and perforate the subchondral bone. Discussion/Conclusion: Scaffold augmentation is a promising technique that improves upon the results of conventional microfracture repair by allowing augmentation with BMAC, as well as giving surgeons the versatility to apply the scaffold on vertical/inverted lesions. BMAC is also a viable alternative source of MSCs for cartilage repair.